News & insights

News & insights

Here we share JMM / KAYAJ brand developments, health education philosophy, product directions, and market insights to help users better understand the brand's approach to proactive and preventive wellness.

Event highlights

Brand event highlights

JMM International signs a 10-year cooperation agreement with Sinopharm International

In November 2023, we signed a 10-year cooperation agreement with Sinopharm International and Sinopharm Health and entered the China market through a dual-brand strategy backed by Sinopharm's resources and channels.

Preventive and proactive wellness: the lifestyle advocated by JMM

We have long advocated preventive and proactive wellness, placing health education and wellness products on the same long-term value chain so users can make informed choices about suitable products and daily wellness practices with stronger professional support.

China's wellness supplement market continues to grow, with imported brands holding the lead

We use public industry data to observe the market. China's wellness supplement market continues to expand, and Australian products remain trusted because of strict regulatory systems and traceable sourcing.

Cross-border e-commerce accelerates wellness supplement market growth

According to Euromonitor data, China's online wellness supplement sales grew from RMB 48.339 billion in 2016 to RMB 116.1 billion in 2020, a five-year CAGR of 25%. Online channels have become a key battleground for major brands, while demand is shifting toward younger consumers who buy primarily for immunity support and weight management.

From Australia to the world: KAYAJ's brand-building journey

We have completed global trademark and domain registration for KAYAJ and continue advancing brand development and globalization. Products began partner recruitment and distribution cooperation in August 2020, and from June 2022 onward we expanded across global e-commerce platforms while pushing offline channel growth.

The amaranth series and product development pipeline continue to advance

We maintain a professional supplement development team and a TGA registration team, while treating the amaranth series development pipeline as a key resource in our 2025 planning. Over the next three to four years, we will continue working with partners on new product development.